AngioDynamics (ANGO) Applauds National Institutes of Health (NIH) and National Institute for Clinical Excellence (NICE)'s Updated Guidelines for Varicose Vein Treatment
8/19/2013 9:14:17 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
ALBANY, N.Y., Aug. 19, 2013 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, applauds the decision by National Institute for Health and Care Excellence (NICE) to issue updated guidance for the treatment of varicose veins. The newly issued guidance establishes endothermal ablation, which includes endovascular laser treatment like the Company's VenaCure EVLT system, as the recommended first option in treating varicose veins.
Help employers find you! Check out all the jobs and post your resume.